Effects of Gender-affirming Hormone Therapy on Transgender People
Launched by NATIONAL TAIWAN UNIVERSITY · Sep 1, 2023
Trial Information
Current as of June 16, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of gender-affirming hormone therapy (GAHT) on transgender individuals who experience gender dysphoria, which is the discomfort or distress that may occur when a person's gender identity does not match their assigned sex at birth. The researchers are looking for 150 participants who are starting GAHT and another 150 who have not begun the treatment yet. The goal is to understand how hormone therapy impacts various aspects of life, including physical health, mental well-being, social interactions, and overall quality of life.
To be eligible for the study, participants need to identify as transgender. Those who join the trial will complete questionnaires and undergo some physical measurements to help researchers gather important information. The findings from this study could provide valuable insights for transgender individuals who are considering hormone therapy, helping to improve guidelines for care and support. The trial is currently recruiting participants aged 18 and older, and it aims to contribute to better understanding and support for the transgender community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • transgender
- Exclusion Criteria:
- • -
About National Taiwan University
National Taiwan University (NTU) is a prestigious academic institution renowned for its commitment to advancing research and education in various fields, including medicine and public health. As a clinical trial sponsor, NTU leverages its extensive expertise and resources to conduct innovative research aimed at improving patient outcomes and addressing critical health challenges. The university fosters a collaborative environment, bringing together multidisciplinary teams of researchers, clinicians, and students to engage in rigorous scientific inquiry and contribute to the development of novel therapies and interventions. Through its clinical trials, NTU aims to enhance the understanding of diseases and promote evidence-based practices in healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported